It’s January, which is typically when many of us are looking into shedding some pounds. We’ve been hearing a lot about how ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

The U.S. FDA has released a new draft guidance for drugmakers to aid them in developing new treatments for obesity. The new ...

Experimental weight-loss drug Retatrutide shows promise, helping obese adults lose up to 22% of their weight in 48 weeks.

With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.

GLP-1 RA drugs help treat diabetes by weight loss, improving blood glucose levels and increasing insulin sensitivity, low ...

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

What does the latest science say about the use of GLP-1 meds to treat obesity in people without diabetes?A review of 26 ...

Soon after beginning to use weight loss drugs, Latisha Doty and Alison Bocking met through a TikTok GLP-1 group in 2022, and they have since found strength in each other as they deal with their weight ...

NHS doctor Ed Robinson says he has seen an increase in people looking for procedures to reverse two 'common concerns' ...